ID

43211

Description

ODM derived from http://clinicaltrials.gov/show/NCT00168051

Link

http://clinicaltrials.gov/show/NCT00168051

Keywords

  1. 12/5/11 12/5/11 -
  2. 4/13/14 4/13/14 - Julian Varghese
  3. 8/10/14 8/10/14 - Martin Dugas
  4. 9/20/21 9/20/21 -
Uploaded on

September 20, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00168051 Hemophilia A

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
18 Years to 64 Years
Description

Age

Data type

boolean

Alias
UMLS CUI-1
C0001779
Male
Description

Male gender

Data type

boolean

Alias
UMLS CUI-1
C0086582
Severe hemophilia A
Description

Severe hemophilia A

Data type

boolean

Alias
UMLS CUI-1
C0019069
Previously treated patients with at least 150 exposure days to any Factor VIII product
Description

Treatment with Factor VIII

Data type

boolean

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0015506
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Hypersensitivity to any recombinant Factor VIII product
Description

Hypersensitivity Factor VIII

Data type

boolean

Alias
UMLS CUI-1
C0020517
UMLS CUI-2
C0015506
History of or current Factor VIII inhibitor
Description

Factor VIII inhibitor

Data type

boolean

Alias
UMLS CUI-1
C0368953
Bleeding episode or other reason requiring Factor VIII treatment within 3 days of study
Description

Bleeding episode

Data type

boolean

Alias
UMLS CUI-1
C0005779

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Age
Item
18 Years to 64 Years
boolean
C0001779 (UMLS CUI-1)
Male
Item
Male
boolean
C0086582 (UMLS CUI-1)
Hemophilia A
Item
Severe hemophilia A
boolean
C0019069 (UMLS CUI-1)
Treatment with Factor VIII
Item
Previously treated patients with at least 150 exposure days to any Factor VIII product
boolean
C0087111 (UMLS CUI-1)
C0015506 (UMLS CUI-2)
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Hypersensitivity Factor VIII
Item
Hypersensitivity to any recombinant Factor VIII product
boolean
C0020517 (UMLS CUI-1)
C0015506 (UMLS CUI-2)
Factor VIII inhibitor
Item
History of or current Factor VIII inhibitor
boolean
C0368953 (UMLS CUI-1)
Bleeding episode
Item
Bleeding episode or other reason requiring Factor VIII treatment within 3 days of study
boolean
C0005779 (UMLS CUI-1)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial